$OHI

Omega Healthcare Investors (OHI) Q2 2026 Earnings Call Transcript

Omega Healthcare Investors (OHI) discussed its Q2 2026 earnings call, focusing on portfolio resilience in skilled nursing and senior housing and capital allocation. It reported Q1 adjusted FFO of $0.83 per share and FAD of $0.78, flat sequentially due to $563 million asset sales. OHI cited 6.7% cap-rate dispositions, operator EBITDAR coverage of 1.65x (as of Mar 31, 2026), a $16 million DIP paydown, and a $480 million CommuniCare asset exit.

Original reporting
Published Aug 8, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 1:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Omega Healthcare Investors (OHI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$OHINeutralMed
01

Why it matters

Investors get near-term earnings context (sequential flat AFFO/FAD due to asset sales), operator credit metrics (EBITDAR coverage trend), and a specific bankruptcy milestone (Genesis closing expected by year-end, with DIP paydown and loan satisfaction expected).

02

Market read

This is a company-specific earnings call with actionable datapoints on sequential earnings pressure, operator coverage improvement, and a year-end catalyst tied to Genesis.

03

What to watch

The transcript excerpt emphasizes expectations and accretion but provides limited detail on the magnitude/timing of redeployment into higher-yield structures, which could affect how much of the optimism is already priced.

Relevance 7/10Novelty 6/10Timing: during/after the Q2 2026 earnings call, with third-quarter impact flagged

Background

The transcript discusses long-run cap-rate dynamics in skilled nursing vs senior housing, portfolio repositioning, and capital allocation products beyond traditional triple-net structures.

Company-level read

Ticker impact

$OHINeutralMedium confidence
Context

Omega Healthcare Investors reported Q2 2026 AFFO and FAD per share, plus a $563 million asset-sale headwind and Genesis bankruptcy progress.

Expected impact

Near-term volatility likely, with downside risk from sequentially flat AFFO/FAD and upside bias if investors buy into redeployment accretion and Genesis timeline.

Evidence & confidence

The article includes concrete datapoints (AFFO/FAD, asset-sale size and cap rate, operator EBITDAR coverage, DIP paydown, Genesis closing timing) but lacks full-year guidance or final deal economics beyond stated expectations.

Market effects

Reinforces REIT read-through that skilled nursing and senior housing cap-rate differentials can compress with aging demand, while operator coverage remains a key underwriting metric.

U.K. care home and U.K. exposure are referenced as part of portfolio evolution, potentially affecting investor focus on cross-border care operators.

Limited direct global linkage beyond the U.K. care home allocation and broader reimbursement/cap-rate narrative.

Counterpoint

Sequential flat AFFO/FAD and the large asset-sale headwind could signal that earnings growth is more dependent on redeployment timing than on organic operating improvement.

Key entities

  • Omega Healthcare Investors

    Subject of the earnings call transcript, providing Q2 2026 AFFO/FAD metrics, asset-sale details, operator coverage updates, and Genesis bankruptcy progress.

  • Genesis

    Strategic sales and bankruptcy process discussed, with closing expected by end of year and lease/economic terms assumed by the buyer.

  • CommuniCare

    18 assets exited for $480 million, with a stated rent discount and credit improvement rationale.

Related articles

$OHIMed

Omega Healthcare Investors Q2 Earnings Call Highlights

Omega Healthcare Investors (OHI) reported Q2 adjusted funds from operations (AFFO) of $261 million, or $0.83/share, and FAD of $248 million, or $0.78/share. The company completed $377 million in new investments and used about $700 million in asset-sale proceeds and loan repayments to cut revolver borrowings to $6 million. OHI raised 2026 AFFO guidance to $3.22-$3.26/share and expects a temporary earnings headwind from late Q2 closings.

$OHIMed

OMEGA HEALTHCARE INVESTORS INC (OHI): Results of Operations and Financial Condition

OMEGA HEALTHCARE INVESTORS INC (OHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ohi-20260729xex99d1.htm EX-99.1 Exhibit 99.1 ​ 303 International Circle P : 410.427.1700 Suite 200 Hunt Valley, MD 21030 ​ PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA REPORTS SECOND QUARTER 2026 RESULTS AND RECENT DEVELOPMENTS Completed $126 Million in New Investments i

$GOODHighAI 9/10

F&P Healthcare weighs on NZX50 ahead of earnings

New Zealand’s S&P/NZX 50 fell 0.2% to 12,970.28 as exporters and property stocks were broadly weaker ahead of Fisher & Paykel Healthcare’s annual earnings on Tuesday and Goodman New Zealand’s results. F&P shares slipped 1.3% to $33.66. Oceania Healthcare rose 2.8% after brokers lifted targets. Outside the index, Pacific Edge gained 3.7% while Eroad fell 8% after missing guidance; Ampfield seeks board control.

$PBMed

Prosperity Bancshares (PB) Q2 2026 Earnings Call

Prosperity Bancshares (PB) reported Q2 2026 net income of $162 million and diluted EPS of $1.62, excluding a Visa Class B-2 stock gain and merger-related expenses, up from $135 million and $1.42 in Q2 2025. Loans rose to $25.0B and deposits to $32.6B. Net interest margin was 3.47%. On July 1, 2026, Prosperity completed its Stellar Bancorp merger.

$HLIMed

Houlihan Lokey (HLI) Q1 2027 Earnings Call Transcript

Houlihan Lokey (HLI) reported Q1 fiscal 2027 revenues of $511 million and adjusted EPS of $1.35. Financial and Valuation Advisory revenues rose 13% to $89 million, while Corporate Finance revenues fell 24% to $303 million and Financial Restructuring revenues were $119 million. Management cited delayed corporate finance deal timelines amid macro headwinds and expects FY adjusted tax rate of 26% to 28%.